Rho is a global contract research organization (CRO) supporting clinical development from first-in-human studies through regulatory approval. Built around science, collaboration, and sponsor-first thinking, the company brings sponsors, investigators, research sites, and patients together to help clinical trials succeed in practice. Rho describes this connected approach as the “Cohesion Effect,” emphasizing strong relationships and shared purpose throughout research.

Its services span clinical delivery and end-in-mind trial design. Clinical capabilities include project management, clinical operations, monitoring, risk-based quality management, pharmacovigilance, biostatistics, statistical programming, and data management. Rho also provides regulatory strategy and submissions, quality assurance, regulatory agency meeting support, integrated analysis and development, marketing application development, and submissions and publishing. Its program strategy services support development planning and execution across development stages and product life cycles.

Rho highlights expertise in neurology and psychiatry, including Parkinson’s disease, as well as respiratory conditions, pain, acute pain, immunology, and government partnerships. The company’s work is focused on helping sponsors navigate complex trials and advance programs toward approval.